Dr Vivek Kumar Jha, CTO, Cilicant & Komal Bhavsar, AGM – Business Development (Pharma),…
FDD Conclave 2024 | Day 1 | 19th July 2024 | Hyderabad
Author
Panel Discussion: ‘The latest and next frontiers in drug formulation’
FDD Conclave 2024 | Day 1 | 19th July 2024 | Hyderabad
FINEARTS-HF trial results in clinically meaningful reduction in the composite endpoint of CV death
The study could be of high clinical value to cardiologists who are seeking an optimal treatment of choice for HF patients, which…
GenAI: Expediting drug discovery while reducing development costs
Raj Babu, Founder & CEO of Agilisium highlights that GenAI is transforming drug discovery by reducing time and costs. By…
How deep tech is transforming drug discovery, manufacturing, and distribution
Madhur Singhal, Managing Partner, Pharma and Lifesciences, Praxis Global Alliance examines how the pharma industry is undergoing a…
Lupin completes Phase 3 Trials for Lucentis Biosimilar
The study has achieved its primary endpoint of therapeutic equivalence in visual acuity improvement for wet AMD patients,…
Sharp decline in pharma funding in July 2024, touches $24.8 mn
As per Tracxn,com, a decline of 84 per cent was observed as funding dropped from $183 million raised in June 2024
Supriya Lifesciences announces new appointees to key leadership positions
Dr Saloni Wagh has been named Managing Director, Shivani Wagh as Joint Managing Director, and Dr Satish Wagh as Executive…
Lupin gets USFDA nod for Prednisolone Acetate Ophthalmic Suspension USP
Lupin was granted a Competitive Generic Therapy designation (CGT) for this product, and being the first approved applicant, Lupin…
DoP implements PLI scheme for pharmaceuticals with a financial outlay of Rs 15,000 cr
The scheme provides a financial incentive to 55 selected applicants for manufacturing of identified products under three…